Stop Watching the Market. Take a Seat at the Table – China & Russia Session at BIOCHINA 2026

At BIOCHINA 2026, taking place from March 12–14 in Suzhou, the China & Russia Session will bring together senior executives from leading pharmaceutical and biotech companies to explore business development, licensing, and cross-border collaboration opportunities.

The session will focus on key topics critical to the China-Russia biopharma landscape, including strategies for business development and licensing, license-in and license-out deals, M&A opportunities, and innovation-driven supply chain collaboration. Participants will have direct access to decision-makers from top pharma and biotech organizations, fostering actionable discussions and concrete cooperation opportunities.

Scheduled for March 13, 2026, at the Suzhou International Expo Center, this session is designed for biotech founders, pharmaceutical BD leaders, investors, and solution providers. It offers a high-efficiency platform to engage with two major biopharma markets through structured presentations and 1V1 partnering meetings.

BIOCHINA 2026 will host over 30,000 participants from more than 40 countries, providing unmatched networking opportunities across the global biopharmaceutical ecosystem.

To register for the China & Russia Session, access the full agenda, speaker list, or support for 1V1 consultations and visas:

Register: https://lnkd.in/giDCUTYr

Learn more: https://lnkd.in/gv3JpqWY

Contact: WhatsApp +86 156 1892 1630 | Email: biochina@enmore.com